Is acupuncture a research-proven treatment-or just a 'theatrical placebo?'

Though studies report a small reduction in pain scores after starting acupuncture, almost the same pattern is seen in patients receiving any type of treatment

Image
ANI Washington
Last Updated : Jun 03 2013 | 12:45 PM IST

Researchers have presented opposing viewpoints regarding the use of acupuncture for pain relief.

Writing in the June issue of Anesthesia and Analgesia, official journal of the International Anesthesia Research Society (IARS), Dr Shu-Ming Wang of University of California-Irvine and colleagues stated, "[C]linical trials support the efficacy of acupuncture in reducing postoperative nausea and vomiting and postoperative pain."

But David Colquhoun, PhD, of University College London and Dr Steven P. Novella of Yale University School of Medicine take a different view, concluding, ""[T]he benefits of acupuncture are likely nonexistent, or at best are too small and too transient to be of any clinical significance."

Both groups of authors evaluate the research literature on acupuncture for management of three problems commonly seen anesthesia practice, for which current drug treatments aren't completely effective: postoperative nausea and vomiting (PONV), postoperative pain, and chronic pain conditions.

Acupuncture studies pose unique challenges, especially in terms of selecting inactive "placebo" comparison treatments.

While acknowledging these difficulties, Dr Wang and coauthors note that many studies have reported benefits of acupuncture. In their view, the evidence is strongest for acupuncture's effectiveness in preventing PONV. One recent research summary, including data on nearly 4,900 patients, concluded that treatment directed at one specific "acupoint" is as effective as conventional drug treatments in preventing PONV, with only minor side effects.

Other studies have reported that acupuncture can reduce the need for pain medication after surgery. Although evidence on chronic pain is mixed, some reports have found acupuncture to be a "reasonable option" for certain conditions, such as knee pain from osteoarthritis. Studies have also supported the cost-effectiveness of acupuncture, showing improvements in health-related quality of life at a small additional cost.

Dr Wang and colleagues also cited brain imaging studies showing different responses to active acupuncture versus inactive treatments. Acupuncture should be viewed as "a medical option that not only treats disorders but also fosters a greater awareness of how harmonic interactions between self, family, work, and environment play a role in promoting health and restoring order," they concluded.

But evaluating the same research, Drs Colquhoun and Novella noted that the largest, highest-quality studies of acupuncture find no significant reduction in pain, compared to inactive treatments.

Though studies typically report a small reduction in pain scores after the start of acupuncture, almost the same pattern is observed in patients receiving any type of treatment, whether active or inactive. Based on the evidence, they write, "It seems that acupuncture is little or no more than a theatrical placebo."

Drs Colquhoun and Novella cited a number of weaknesses in the research evidence, including selectively focusing on a few positive results and "publication bias"-publishing only those studies that show positive effects of acupuncture.

They noted that even for PONV-the problem with the strongest body of evidence-most studies supporting acupuncture were performed by one group of researchers, with significant scientific weaknesses.

With this history of "variable and inconsistent" results, acupuncture should be regarded as "an inactive intervention," Drs Colquhoun and Novella believe.

"Since it has proved impossible to find consistent evidence after more than 3000 trials, it is time to give up," they concluded.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 03 2013 | 11:24 AM IST

Next Story